Valuation AstraZeneca PLC NYSE

Stocks

Real-time Estimate Cboe BZX Other stock markets 12:06:44 30/07/26 am AEST			5-day change	1st Jan Change
174.74 ^USD	+1.31%		+1.85%	+89.22%

10:09pm	ASTRAZENECA : Gets a Buy rating from Bernstein	ZD
06:30pm	Deutsche Bank cuts Diageo and Luceco	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	267,012	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-7.23%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	287,066	279,575	271,734
Change	-	12.57%	-0.25%	-1.74%	36.64%	-7.75%	-2.61%	-2.8%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	22x	19.2x	16.7x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.96x	4.4x	3.74x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.3x	1.1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.22x	3.99x	3.74x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.54x	4.18x	3.81x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	12.9x	11.4x	10.1x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	13.6x	12x	10.6x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	29.9x	21.6x	18.9x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.35%	4.64%	5.29%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.325	3.527	3.662
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.93%	2.05%	2.13%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.815	8.959	10.33
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	42.5%	39.4%	35.5%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,290	66,837	71,311
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,338	24,438	26,859
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,092	23,272	25,589
Net income ¹	112	3,288	5,961	7,035	10,225	12,085	13,710	15,677
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	20,054	12,563	4,722
Reference price ²	117.51	135.16	135.02	131.05	185.60	172.15	172.15	172.15
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	10/2/22	9/2/23	8/2/24	6/2/25	10/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	36.25x	12.94x	27.18x	0.55%	1,089B
JOHNSON & JOHNSON	28.59x	6.53x	18.09x	2.01%	643B
ABBVIE INC.	33.13x	7.75x	15.94x	2.61%	465B
ROCHE HOLDING AG	20.2x	4.86x	12.04x	2.72%	359B
NOVARTIS AG	22.65x	5.84x	14.57x	2.74%	303B
NOVO NORDISK A/S	14.79x	5.48x	11.3x	3.38%	226B
AMGEN INC.	25.81x	6.73x	11.86x	2.57%	212B
GILEAD SCIENCES, INC.	-48.4x	5.8x	32.01x	2.45%	167B
PFIZER INC.	12.82x	3.13x	7.91x	6.82%	144B
Average	16.21x	6.56x	16.77x	2.87%	400.89B
Weighted average by Cap.	24.94x	8.17x	19.10x	2.11%